Equities

InnovAge Holding Corp

INNV:NSQ

InnovAge Holding Corp

Actions
Health CareHealth Care Providers
  • Price (USD)4.86
  • Today's Change0.23 / 4.97%
  • Shares traded16.33k
  • 1 Year change-12.27%
  • Beta0.3185
Data delayed at least 15 minutes, as of Nov 22 2024 17:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

  • Revenue in USD (TTM)786.51m
  • Net income in USD-15.96m
  • Incorporated2015
  • Employees2.35k
  • Location
    InnovAge Holding Corp8950 E. Lowry BoulevardDENVER 80230United StatesUSA
  • Phone+1 (303) 869-4664
  • Fax+1 (302) 655-5049
  • Websitehttps://www.innovage.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Viemed Healthcare Inc214.30m10.43m339.14m996.0033.892.719.561.580.2570.2575.283.211.3418.969.53215,161.606.5612.288.4015.5260.2862.574.8810.091.199.020.04890.0031.8223.2164.631.5033.67--
Enhabit Inc1.04bn-116.60m375.62m10.80k--0.6637--0.3622-2.32-2.3220.6511.250.7529--6.5196,037.04-8.28---9.49--48.79---11.00----0.66080.468---2.32---99.26------
Airsculpt Technologies Inc188.78m-7.79m390.47m346.00--4.75105.052.07-0.1373-0.13733.271.430.9156--52.88545,606.90-3.78---4.24--64.98---4.13----1.980.4594--16.07--69.49------
DocGo Inc694.97m30.83m420.45m2.92k14.511.299.100.6050.2840.2846.413.191.52--3.15238,411.106.35--8.97--34.50--4.17----61.050.1194--41.72---80.17------
Sonida Senior Living Inc278.12m-16.60m467.22m2.62k--6.0319.661.68-2.13-2.1322.486.750.3903--26.74106,272.50-1.64-6.63-1.90-8.19-----4.20-18.04---0.19160.8163--7.08-11.1155.74---3.97--
Fulgent Genetics Inc277.76m-164.97m518.45m1.18k--0.4547--1.87-5.53-5.539.2537.280.2143--5.21234,595.40-13.2716.70-14.0018.3736.2267.89-61.9129.06----0.00080.00-53.2768.41-217.03--57.08--
Community Health Systems Inc12.55bn-398.00m521.06m61.00k----2.270.0415-3.00-3.0095.32-13.120.87846.085.97205,770.50-1.740.7566-2.150.938184.6083.69-1.980.93451.320.98341.12--2.28-2.47-389.13---2.39--
Talkspace Inc181.29m-1.37m559.13m472.00--4.75--3.08-0.0085-0.00851.070.69651.30--20.63384,091.10-0.985---1.15--47.04---0.7568------0.00--25.49--75.92------
InnovAge Holding Corp786.51m-15.96m627.35m2.35k--2.40279.940.7976-0.1175-0.11755.791.931.47--17.30334,686.00-3.35-3.72-4.76-4.9017.6420.39-2.28-2.79---2.300.2172--11.0110.4147.54---11.39--
Agilon Health Inc5.35bn-306.78m733.39m1.12k--1.28--0.137-0.7574-0.952113.131.402.45--3.954,792,792.00-14.04---36.97--2.00---5.73------0.0572--80.74---112.01------
QDM International Inc3.93m1.30m790.14m5.00606.26180.97587.92201.150.00450.00450.01350.0150.5994--21.84785,618.0019.86--34.36--61.80--33.13----436.130.2444--461.81--3,411.87------
Data as of Nov 22 2024. Currency figures normalised to InnovAge Holding Corp's reporting currency: US Dollar USD

Institutional shareholders

12.08%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Investment Management, Inc.as of 30 Sep 20244.76m3.51%
Coliseum Capital Management LLCas of 30 Sep 20243.94m2.91%
The Vanguard Group, Inc.as of 30 Sep 20241.81m1.34%
Kent Lake Capital LLCas of 30 Jun 20241.77m1.30%
Kent Lake Pr LLCas of 30 Sep 20241.42m1.04%
BlackRock Fund Advisorsas of 30 Sep 20241.14m0.84%
Geode Capital Management LLCas of 30 Sep 2024527.96k0.39%
SSgA Funds Management, Inc.as of 30 Sep 2024344.91k0.26%
Welch Capital Partners LLCas of 30 Sep 2024337.56k0.25%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2024315.20k0.23%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.